Search research articles
Contact Us
Filters
Showing results (261-270 of 516) with videos related to
Page
of 52
Sort By:
Cancer
|
January 9, 2020
Venous thromboembolism risk with contemporary lenalidomide-based regimens despite thromboprophylaxis in multiple myeloma: A systematic review and meta-analysis
Rajshekhar Chakraborty, Irbaz Bin Riaz, Saad Ullah Malik, et al.
Blood Cancer Journal
|
November 21, 2025
Defining the proteome of bone marrow plasma in multiple myeloma and monoclonal gammopathy of undetermined significance
Joel-Sean Hsu, Udit Yadav, Kishore Garapati, et al.
Annals of Hematology
|
December 3, 2025
Outcomes in patients with relapsed/refractory multiple myeloma with extramedullary disease: a meta-analysis
Peter M Voorhees, Shaji Kumar, Saad Z Usmani, et al.
Haematologica
|
September 2, 2024
Comparing the clinical trial efficacy <i>versus</i> real-world effectiveness of treatments for multiple myeloma: a population-based study
Alissa Visram, Kelvin Kar-Wing Chan, Hsien Seow, et al.
Research Square
|
November 14, 2023
Mode of Progression in Smoldering Multiple Myeloma: A study of 406 patients
S Rajkumar, Nadine Abdallah, Arjun Lakshman, et al.
Bone Marrow Transplantation
|
December 4, 2020
Autologous stem cell transplantation for multiple myeloma patients aged ≥ 75 treated with novel agents
Iuliana Vaxman, Alissa Visram, Shaji Kumar, et al.
Blood
|
May 5, 2005
Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis
Kenji Ishitsuka, Teru Hideshima, Makoto Hamasaki, et al.
Bone Marrow Transplantation
|
November 19, 2020
Depth of response prior to autologous stem cell transplantation predicts survival in light chain amyloidosis
Iuliana Vaxman, M Hasib Sidiqi, Abdullah S Al Saleh, et al.
Blood
|
March 17, 2012
Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma
Shaji Kumar, Ian Flinn, Paul G Richardson, et al.
Haematologica
|
June 5, 2013
A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision?
Nelson Leung, Siobhan V Glavey, Shaji Kumar, et al.
Page
of 52
Search research articles
Search
Showing results (261-270 of 516) with videos related to
Sort By:
Page
of 52
Cancer
|
January 9, 2020
Venous thromboembolism risk with contemporary lenalidomide-based regimens despite thromboprophylaxis in multiple myeloma: A systematic review and meta-analysis
Rajshekhar Chakraborty, Irbaz Bin Riaz, Saad Ullah Malik, et al.
Blood Cancer Journal
|
November 21, 2025
Defining the proteome of bone marrow plasma in multiple myeloma and monoclonal gammopathy of undetermined significance
Joel-Sean Hsu, Udit Yadav, Kishore Garapati, et al.
Annals of Hematology
|
December 3, 2025
Outcomes in patients with relapsed/refractory multiple myeloma with extramedullary disease: a meta-analysis
Peter M Voorhees, Shaji Kumar, Saad Z Usmani, et al.
Haematologica
|
September 2, 2024
Comparing the clinical trial efficacy <i>versus</i> real-world effectiveness of treatments for multiple myeloma: a population-based study
Alissa Visram, Kelvin Kar-Wing Chan, Hsien Seow, et al.
Research Square
|
November 14, 2023
Mode of Progression in Smoldering Multiple Myeloma: A study of 406 patients
S Rajkumar, Nadine Abdallah, Arjun Lakshman, et al.
Bone Marrow Transplantation
|
December 4, 2020
Autologous stem cell transplantation for multiple myeloma patients aged ≥ 75 treated with novel agents
Iuliana Vaxman, Alissa Visram, Shaji Kumar, et al.
Blood
|
May 5, 2005
Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis
Kenji Ishitsuka, Teru Hideshima, Makoto Hamasaki, et al.
Bone Marrow Transplantation
|
November 19, 2020
Depth of response prior to autologous stem cell transplantation predicts survival in light chain amyloidosis
Iuliana Vaxman, M Hasib Sidiqi, Abdullah S Al Saleh, et al.
Blood
|
March 17, 2012
Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma
Shaji Kumar, Ian Flinn, Paul G Richardson, et al.
Haematologica
|
June 5, 2013
A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision?
Nelson Leung, Siobhan V Glavey, Shaji Kumar, et al.
Page
of 52